Holen Sie sich die Stockscreener-App
12.95
3.35%
0.42
Handel nachbörslich:
12.95
Schlusskurs vom Vortag:
$12.53
Offen:
$12.71
24-Stunden-Volumen:
617.57K
Relative Volume:
1.74
Marktkapitalisierung:
$435.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-47.20M
KGV:
-8.2732
EPS:
-1.5653
Netto-Cashflow:
$-43.65M
1W Leistung:
+10.97%
1M Leistung:
-0.69%
6M Leistung:
+44.05%
1J Leistung:
+0.00%
1-Tages-Spanne:
$12.48
$14.28
1-Wochen-Bereich:
$10.11
$14.28
52-Wochen-Spanne:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Firmenname
Mbx Biosciences Inc
Sektor
Branche
Telefon
(317) 989-3100
Adresse
11711 N. MERIDIAN STREET, CARMEL
Vergleichen Sie MBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
12.95 | 420.93M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Eingeleitet | Mizuho | Outperform |
| 2025-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2025-04-10 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Eingeleitet | Guggenheim | Buy |
| 2024-10-08 | Eingeleitet | JP Morgan | Overweight |
| 2024-10-08 | Eingeleitet | Jefferies | Buy |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
Alle ansehen
Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten
How to track smart money flows in MBX Biosciences Inc.July 2025 EndofMonth & Real-Time Market Sentiment Alerts - Newser
What to do if you’re stuck in MBX Biosciences Inc.July 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Can volume confirm reversal in MBX Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Volatility clustering patterns for MBX Biosciences Inc.July 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Can a trend reversal in MBX Biosciences Inc. lead to recovery2025 Top Decliners & Free Risk Controlled Daily Trade Plans - Newser
How to use a screener to detect MBX Biosciences Inc. breakoutsJuly 2025 Decliners & Target Return Focused Picks - Newser
MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
MBX Biosciences Triggers Bullish KDJ Golden Cross and Marubozu - AInvest
MBX Biosciences Inc. recovery potential after sell offSector Rotation Strategy for Smart Traders - Newser
Using economic indicators to assess MBX Biosciences Inc. potentialSector-Wise Equity Performance Trend Forecast - Newser
MBX Biosciences Reports Progress and Financial Stability - TipRanks
Tools to assess MBX Biosciences Inc.’s risk profileTriple Digit Gain Opportunity Watchlist - Newser
Technical signs of recovery in MBX Biosciences Inc.Free Reliable Investment Entry Point Signals - Newser
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Market Surge Signal for Swing Traders - Newser
Applying big data sentiment scoring on MBX Biosciences Inc.Free ROI Driven Equity Selection With Safety - Newser
What’s next for MBX Biosciences Inc. stock priceFree Low Volatility Stable Growth Picks - Newser
How does MBX Biosciences Inc. compare to its peers3x ROI Investment Watch - thegnnews.com
MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Mizuho - MarketBeat
Technical analysis overview for MBX Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
Is MBX Biosciences Inc. forming a reversal patternSwing Trade Picks with High Potential - Newser
MBX Biosciences Inc. Forms Bullish Flag — Upside AheadBreakout Entry Signal Confirmation Tool Used - beatles.ru
MBX Biosciences (NYSE:MBX) Research Coverage Started at Mizuho - Defense World
Mbx Biosciences (MBX) Q2 Loss Widens 22% - Nasdaq
MBX Biosciences Q2 revenue $224.9mln, cash to support operations into mid-2027. - AInvest
MBX Biosciences reports Q2 revenue, cash, and pipeline progress. - AInvest
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
MBX Biosciences Reveals Triple Clinical Trial Progress, Secures 2-Year Cash Runway With $224M - Stock Titan
How MBX Biosciences Inc. stock performs during market volatilitySmart Entry Signals for Active Traders - Newser
Mizuho Securities Initiates MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $38 - 富途牛牛
Analyst Upgrades and Initiations for Tuesday: Lionsgate Studios, MBX Biosciences, D-Wave Quantum, APA Corporation, and Quince Therapeutics - AInvest
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
MBX Biosciences: Mizuho Initiates Coverage on Outperform with $38 PT - AInvest
Mizuho Initiates MBX Biosciences at Outperform - MarketScreener
Mizuho initiates MBX Biosciences stock with Outperform rating on promising pipeline - Investing.com Nigeria
MBX Biosciences initiated with an Outperform at Mizuho - TipRanks
RSI Crosses Above 30 for MBX Biosciences Inc. — Reversal in SightSector Rotation Based Trading Opportunities Identified - metal.it
What is MBX Biosciences Inc. company’s growth strategyCapitalize on fast-moving stock trends - Jammu Links News
What is the dividend policy of MBX Biosciences Inc. stockInvest smarter with advanced market data - Jammu Links News
When is MBX Biosciences Inc. stock expected to show significant growthFree High-Return Strategy Alerts - Jammu Links News
Finanzdaten der Mbx Biosciences Inc-Aktie (MBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):